Dyadic International, Inc. (DYAI) vs NextCure, Inc. (NXTC)
A side-by-side comparison of Dyadic International, Inc. and NextCure, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DYAI
Dyadic International, Inc.
$0.45HealthcareDelayed quote: Oct 6, 2026, 11:59 AM EDT
NXTC
NextCure, Inc.
$5.30HealthcareDelayed quote: Oct 6, 2026, 11:32 AM EDT
Total return — DYAI vs NXTC
growth of $100 · dividends reinvested · last 7yDYAI -86.2% (-24.7%/yr)NXTC -97.9% (-42.4%/yr)DYAI compounded faster over this window
Log scale — wide-divergence pair
DYAI NXTC
DYAI vs NXTC: by the numbers
- •NXTC is the larger company ($19M vs $16M market cap).
- •Both run net losses; NXTC's is the smaller (0.00% vs -219.50% net margin).
Metrics side by side
Valuation
| Metric | DYAI | NXTC |
|---|---|---|
| P/S ratio | 4.75 | N/A |
| P/B ratio | N/A | 1.58 |
Profitability
| Metric | DYAI | NXTC |
|---|---|---|
| Gross margin | -88.25% | 0.00% |
| Operating margin | -579.88% | 0.00% |
| Net margin | -219.50% | 0.00% |
| ROE | N/A | -351.86% |
| ROIC | -279.48% | -259.91% |
Growth (annualized)
| Metric | DYAI | NXTC |
|---|---|---|
| Revenue CAGR (5Y) | -5.11% | N/A |
| Total return CAGR (5Y) | -38.53% | -44.29% |
Frequently asked
- How have DYAI and NXTC total returns compared?
- Over the past 5 years, DYAI delivered -38.53% and NXTC delivered -44.29% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.